Antiretroviral drugs for preventing mother-to-child transmission of HIV in sub-Saharan Africa: balancing efficacy and infant toxicity.
about
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant womenIs protease inhibitors based antiretroviral therapy during pregnancy associated with an increased risk of preterm birth? Systematic review and a meta-analysisInfant peripheral blood repetitive element hypomethylation associated with antiretroviral therapy in uteroWHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: modeling clinical outcomes in infants and mothersWhat will it take to eliminate pediatric HIV? Reaching WHO target rates of mother-to-child HIV transmission in Zimbabwe: a model-based analysisOperations research in global health: a scoping review with a focus on the themes of health equity and impactMitochondrial toxicity in human pregnancy: an update on clinical and experimental approaches in the last 10 years.Safety of in utero and neonatal antiretroviral exposure: cognitive and academic outcomes in HIV-exposed, uninfected children 5-13 years of age.Mother-to-child transmission of HIV and its predictors among HIV-exposed infants at a PMTCT clinic in northwest Ethiopia.Impact of antiretroviral therapy on fertility desires among HIV-infected persons in rural Uganda.Married men's perceptions of barriers for HIV-positive pregnant women accessing highly active antiretroviral therapy in rural Uganda.[Study of risk factors for HIV transmission from mother to child in the strategy «option A» in Lubumbashi, Democratic Republic of Congo]Safety of perinatal exposure to antiretroviral medications: developmental outcomes in infants.What is needed to eliminate new pediatric HIV infections: the contribution of model-based analyses.In utero exposure to antiretrovirals and neurodevelopment among HIV-exposed uninfected children in Botswana.A systematic review and meta-analysis of vertical transmission route of HIV in Ethiopia.
P2860
Q24236763-F5A5D877-C3B2-4443-BCD8-63DA7E4A218EQ28066290-B4122CDB-031E-4EB1-90C9-3DE4A5364B60Q28392255-A0B9799C-7D2D-47DC-9315-7D09A69F5F6BQ28478406-1C341437-649F-43D9-B548-D97ED9428C5FQ28478769-7CDE9C92-96D9-4C04-9000-72E6F0F41817Q29994616-B9CD484E-51F3-49BA-AC6E-DB391EB71F45Q34348392-C30BC050-C1D5-435D-BE5F-8835CC5469A2Q34440361-E83A6CAB-23C5-4296-ABEA-0633744F95DDQ34690285-ECA3C600-C9A4-45CD-8383-5B6FFB26F668Q35545987-83513908-2825-436B-B12E-0C6C374039BFQ36008834-DD004A64-4DC1-4551-AD91-038B17A16815Q36284041-8B4A228B-B7AD-476A-8DB7-B79100B9B031Q37045192-DDCB8F92-F5B3-46C4-A9F9-DE21FA2DD5EBQ37238095-0EF00803-37F2-4A15-B00A-EF7E8FB53143Q51365493-D870B451-E5EB-4D55-9359-ADB671BAF4B7Q55421183-8EF606F7-D884-43E6-9FF9-084665092384
P2860
Antiretroviral drugs for preventing mother-to-child transmission of HIV in sub-Saharan Africa: balancing efficacy and infant toxicity.
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Antiretroviral drugs for preve ...... efficacy and infant toxicity.
@ast
Antiretroviral drugs for preve ...... efficacy and infant toxicity.
@en
type
label
Antiretroviral drugs for preve ...... efficacy and infant toxicity.
@ast
Antiretroviral drugs for preve ...... efficacy and infant toxicity.
@en
prefLabel
Antiretroviral drugs for preve ...... efficacy and infant toxicity.
@ast
Antiretroviral drugs for preve ...... efficacy and infant toxicity.
@en
P2860
P50
P921
P1433
P1476
Antiretroviral drugs for preve ...... efficacy and infant toxicity.
@en
P2093
Andrea L Ciaranello
George R Seage
P2860
P304
P356
10.1097/QAD.0B013E3283189BD7
P407
P577
2008-11-01T00:00:00Z